Koers Uluru Inc OTC Bulletin Board
Aandelen
US90403T2096
Farmaceutische producten
Omzet 2016 | 443K 408K | Omzet 2017 | 717K 661K | Marktkapitalisatie | 5,93 mln. 5,46 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -4 mln. -3,68 mln. | Nettowinst (verlies) 2017 | -1 mln. -921K | EV/omzet 2016 | 5,33 x |
Nettoliquiditeiten 2016 | 16,62K 15,31K | Nettoliquiditeiten 2017 | 3,14 mln. 2,89 mln. | EV/omzet 2017 | 3,89 x |
K/w-verhouding 2016 |
-0,48
x | K/w-verhouding 2017 |
-1,91
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vaidehi Shah
CEO | Chief Executive Officer | 47 | 27-02-17 |
Oksana Tiedt
CTO | Chief Tech/Sci/R&D Officer | 48 | 31-03-17 |
Anish Shah
BRD | Director/Board Member | - | 31-03-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Oksana Tiedt
CTO | Chief Tech/Sci/R&D Officer | 48 | 31-03-17 |
Director/Board Member | 57 | 20-07-15 | |
Vaidehi Shah
CEO | Chief Executive Officer | 47 | 27-02-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,59% | 727 mld. | |
-7,89% | 354 mld. | |
+15,66% | 328 mld. | |
+0,24% | 277 mld. | |
+13,47% | 243 mld. | |
+7,35% | 205 mld. | |
-6,42% | 203 mld. | |
+4,23% | 164 mld. | |
-1,70% | 164 mld. |